These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706 [TBL] [Abstract][Full Text] [Related]
8. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294 [TBL] [Abstract][Full Text] [Related]
9. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin. Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825 [TBL] [Abstract][Full Text] [Related]
10. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Bakari M; Aboud S; Nilsson C; Francis J; Buma D; Moshiro C; Aris EA; Lyamuya EF; Janabi M; Godoy-Ramirez K; Joachim A; Polonis VR; Bråve A; Earl P; Robb M; Marovich M; Wahren B; Pallangyo K; Biberfeld G; Mhalu F; Sandström E Vaccine; 2011 Oct; 29(46):8417-28. PubMed ID: 21864626 [TBL] [Abstract][Full Text] [Related]
11. Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. Cheeseman HM; Day S; McFarlane LR; Fleck S; Miller A; Cole T; Sousa-Santos N; Cope A; Cizmeci D; Tolazzi M; Hwekwete E; Hannaman D; Kratochvil S; McKay PF; Chung AW; Kent SJ; Cook A; Scarlatti G; Abraham S; Combadiere B; McCormack S; Lewis DJ; Shattock RJ Hum Gene Ther; 2018 Sep; 29(9):1011-1028. PubMed ID: 30027768 [TBL] [Abstract][Full Text] [Related]
12. Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled Trial. Viegas EO; Tembe N; Nilsson C; Meggi B; Maueia C; Augusto O; Stout R; Scarlatti G; Ferrari G; Earl PL; Wahren B; Andersson S; Robb ML; Osman N; Biberfeld G; Jani I; Sandström E AIDS Res Hum Retroviruses; 2018 Feb; 34(2):193-205. PubMed ID: 28969431 [TBL] [Abstract][Full Text] [Related]
13. In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses. Wang Q; Jiang W; Chen Y; Liu P; Sheng C; Chen S; Zhang H; Pan C; Gao S; Huang W J Virol; 2014 Feb; 88(4):1924-34. PubMed ID: 24284319 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Dobaño C; Widera G; Rabussay D; Doolan DL Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562 [TBL] [Abstract][Full Text] [Related]
15. Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation. LeBlanc R; Vasquez Y; Hannaman D; Kumar N Vaccine; 2008 Jan; 26(2):185-92. PubMed ID: 18054817 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2. Tian DY; Sun Y; Wai SF; Lee FK; Meng QL; Suen KM; Wang N; Han W; Li S; Li YF; Li D; Ling LJ; Liao YJ; Qiu HJ Vaccine; 2012 May; 30(24):3587-94. PubMed ID: 22469861 [TBL] [Abstract][Full Text] [Related]
17. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Hirao LA; Wu L; Khan AS; Hokey DA; Yan J; Dai A; Betts MR; Draghia-Akli R; Weiner DB Vaccine; 2008 Jun; 26(25):3112-20. PubMed ID: 18430495 [TBL] [Abstract][Full Text] [Related]
18. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device. Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496 [TBL] [Abstract][Full Text] [Related]
19. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells. Muthumani G; Laddy DJ; Sundaram SG; Fagone P; Shedlock DJ; Kannan S; Wu L; Chung CW; Lankaraman KM; Burns J; Muthumani K; Weiner DB Immunology; 2009 Sep; 128(1 Suppl):e612-20. PubMed ID: 19740322 [TBL] [Abstract][Full Text] [Related]
20. A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults. Mpendo J; Mutua G; Nyombayire J; Ingabire R; Nanvubya A; Anzala O; Karita E; Hayes P; Kopycinski J; Dally L; Hannaman D; Egan MA; Eldridge JH; Syvertsen K; Lehrman J; Rasmussen B; Gilmour J; Cox JH; Fast PE; Schmidt C PLoS One; 2015; 10(8):e0134287. PubMed ID: 26252526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]